ArticleScientific reports2022

Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.

Kazuo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.